(1) known in the scientific sense? post the ref. AFAICT this appears to be a reference to Nukes musings on the subject.
(2) as for methcathinone's effects on serotonin please just read the paper YOU cited and the references therein.
or are you getting confused again, however the nomal English usage of former is first, and latter is last.
I think you really need to get your head round pharmacology,
a substrate for a transporter protein is yes you guessed it something that is transported by said transporter.
SSRI'S do not, at normal clinical doses, block all SERT activity.
Only some SSRI's block the subjective effects of MDMA.
Serotonin syndrome is not an inevitable consequence of mixing a SE releaser and a SSRI, nether is it inevitable with a SE releaser and a MAOI or all three at once.
come back when you can post stuff that:
1, makes sense
2 is supported by scientific literature where possible, or doesn't blatently contradict the literature.
3 that doesn't contradict itself.
4 and shows that you actually have the faintest clue what you are talking about
I am not going to bother answering you in future until you meet 1 thru 4( see above)
Have a nice day.
I will attempt to meet some of your requests, if only to try and reverse some of the misrepresentation I am attracting. Please note that while I find your hypocrisy wildly entertaining, it worries me a little that you are a moderator on a thread dedicating itself to advanced drug discussion at all.
1) You really ought to know this one. MDMA releases serotonin. Taken from
http://www.psychotropical.com/CNS_stimulants_with_MAOIs.shtml
Large doses of MDMA cause a rapid release of endogenous serotonin from the stores in the presynaptic nerves; so much so that a substantial MDMA dose will deplete about eighty percent of the serotonin stores
Please look literally anywhere for scientific literature supporting this claim.
Being new to the board, I have never heard of Nuke, so sorry, no.
2) Friend, it would appear YOU are the one who hasn't read the paper. You've TWICE failed to grasp either of the two conclusions the author(s) made:
a) Those being that methcat is a substrate inhibitor (IT'S IN THE TITLE)
(from the paper discussed)
"We previously reported that the psychostimulant drug methcathinone inhibits serotonin accumulation via the plasma membrane serotonin uptake transporter."
b) And that a superfusion of the drug causes efflux/release of serotonin
"Supporting the hypothesis, superfusion of [3H]5-HT-containing platelets with methcathinone or with para-methylthioamphetamine produced a large increase in tritium efflux. The efflux declined when the drugs were removed."
and also
"...Under superfusion conditions, transporter substrates will evoke an increase in released [3H]5-HT through a carrier-mediated exchange process."
however the nomal English usage of former is first, and latter is last.
By the by, I understand the correct use of former and latter. I happened to write the post on 2 hours of rough sleep spent in questionable comfort, so I assume you'll overlook a simple human error anyone of us could have made. Now hold on, you'd know about those...
SSRI'S do not, at normal clinical doses, block all SERT activity.
Only some SSRI's block the subjective effects of MDMA.
Again, from
http://www.psychotropical.com/CNS_stimulants_with_MAOIs.shtml
MDMA, ecstasy (3,4-methylenedioxymethamphetamine) acts like tyramine, but seemingly more as a releaser of serotonin than noradrenaline, and its serotonergic action is blocked by serotonin reuptake inhibitors [14].
Let's take citlopram for example. The 'purest' SSRI (bar escitalopram, its isometrically cleaved relative)
http://www.nature.com/npp/journal/v22/n5/full/1395472a.html
"
The main result of this study is that the psychoactive effects of 1.5 mg/kg MDMA were substantially attenuated by pretreatment with the SSRI citalopram (40 mg iv)."
Note an earlier Ricaurte study of showed pretreatment of fluoxetine 20mg failed to attenuate serotonin release in rats dosed with mdma, the author suggesting a possible discrepancy in relative ability to block uptake of 5-HT between citalopram 40mg and fluoxetine 20mg as the cause. I suggest other factors relating to errors in the experiment, probably that the wrong test compound was used in the first place, if it forms part of a series relating to his other studies on mdma. The report below contradicts Ricaurte's findings and, if correct proves SRRIs PREVENT MDMA FROM WORKING. PLEASE PROVE OTHERWISE.
Fluoxetine: arguably the'dirtiest' SSRI in vivo (sertraline being a significant DRI in vitro) which despite being the first SSRI to be heavily marketed as such, is, in its ability to block 5HT-2C receptors, atypical of its class. Malonate is used in the study as a catalyst to mdma-induced neurotoxicity via 5-HT release. From
http://jop.sagepub.com/cgi/content/abstract/20/2/245
"
in this study we sought to determine whether pharmacological blockade of MDMA- and/or malonateinduced dopamine release prevents neurotoxicity. Fluoxetine, given 30 min prior to the malonate/MDMA combination, afforded complete protection against 5-HT depletion and reversed MDMA-induced exacerbation of dopamine toxicity found in the malonate/MDMA treated rats."
3) "Serotonin syndrome is not an inevitable consequence of mixing a SE releaser and a SSRI"
Well...um, duh. Why, if you know what you're talking about, would you even make such an obvious statement. Serotonin syndrome is AVERTED by taking an SSRI since, as I have made clear, it attenuates 99% of MDMAs ability to release 5-HT.
Are your terms met? Are you satisfied. I hope so.